Alpha Tau Medical Ltd. — Form 6-K Summary
Reporting period: Form 6-K furnished for March 2023; dated March 29, 2023. The filing reports that the company issued a press release titled “Alpha Tau Medical to Present at Jefferies Radiopharma Innovation Summit.”
Business Context
Alpha Tau Medical is an Israeli medical technology company. The filing contains the company’s announcement regarding its planned presentation at the Jefferies Radiopharma Innovation Summit. The referenced press release is filed as Exhibit 99.1, but its substantive presentation details are not included in the provided filing text.
Financial Metrics
The filing does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material Changes
The filing text does not identify material changes versus a prior comparable period.
Guidance, Outlook, Risks and Unusual Items
No financial guidance, forecasts, risk disclosures, contingencies, or unusual items are provided in the available text. The company notes that the Form 6-K information, including Exhibit 99.1, is furnished and generally is not deemed filed under Section 18 of the Exchange Act or incorporated by reference into other filings unless specifically stated.
Key Facts to Verify
- Review Exhibit 99.1 for the presentation date, time, webcast details, and any business or clinical updates.
- Confirm whether the investor presentation includes new information regarding Alpha Tau’s Alpha DaRT technology, clinical programs, regulatory status, or commercial plans.
- Refer to the company’s applicable Form 20-F and subsequent filings for financial results, liquidity, financing needs, and risk factors.